Anebulo Pharmaceuticals Inc (ANEB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 2,260 | 2,331 | 1,892 | 2,588 | 2,412 |
| Operating Income | -2,260 | -2,331 | -1,892 | -2,588 | -2,412 |
| Interest Expense | 17 | 17 | 245 | 60 | 60 |
| Other Income | 120 | 203 | 461 | 185 | 272 |
| Pre-tax Income | -2,158 | -2,145 | -1,676 | -2,463 | -2,200 |
| Net Income Continuous | -2,158 | -2,145 | -1,676 | -2,463 | -2,200 |
| Net Income | $-2,158 | $-2,145 | $-1,676 | $-2,463 | $-2,201 |
| EPS Basic Total Ops | -0.05 | -0.04 | -0.04 | -0.09 | -0.08 |
| EPS Basic Continuous Ops | -0.05 | -0.04 | -0.04 | -0.09 | -0.08 |
| EPS Diluted Total Ops | -0.05 | -0.04 | -0.04 | -0.09 | -0.08 |
| EPS Diluted Continuous Ops | -0.05 | -0.04 | -0.04 | -0.09 | -0.08 |
| EPS Diluted Before Non-Recurring Items | -0.05 | -0.05 | -0.04 | -0.09 | -0.08 |
| EBITDA(a) | $-2,243 | $-2,313 | $-1,647 | $-2,529 | $-2,352 |